SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-21-355373
Filing Date
2021-12-13
Accepted
2021-12-13 16:03:17
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 d151047d424b3.htm 424B3 101106
2 GRAPHIC g151047g1201211915589.jpg GRAPHIC 5404
  Complete submission text file 0001193125-21-355373.txt   109711
Mailing Address 4224 CAMPUS POINT COURT SUITE 210 SAN DIEGO CA 92121
Business Address 4224 CAMPUS POINT COURT SUITE 210 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-261469 | Film No.: 211488101
SIC: 2834 Pharmaceutical Preparations